US pharma giant Merck & Co has applied to the US Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its oral antiviral drug molnupiravir...
Another “Big Pharma” company with a stalled candidate of its own is stepping in to help boost national or regional Covid-19 vaccine supply. US president Joe Biden was due...
US pharma giant Merck has divested its direct holding in Moderna just as the US biotech is on the cusp of receiving an emergency use authorization (EUA) for its mRNA...
12.06.2019
- Keytruda, the multi-indication oncology drug manufactured by US Merck & Co, has won approval from the Food and Drug Administration (FDA) for both monotherapy and combination...
23.05.2019
- US drugmaker Merck & Co. is to buy Peloton Therapeutics in a deal that could be worth as much as $2.2 billion to the clinical-stage biopharma. The acquisition would give Merck...
30.04.2019
- Two months earlier than expected, the US Food and Drug Administration (FDA) has greenlighted the use of Merck & Co’s multi-indication cancer treatment Keytruda in combination with...
19.12.2018
- Merck & Co has agreed to acquire French animal health company Antelliq for a cash payment of about €2.1 billion. Upon completion of the deal, expected in the second quarter of 2019...
22.08.2016
- Pfizer has won the race for biotech firm Medivation. The US drugs giant has agreed to pay about $14 billion in a move that adds leading prostate cancer drug Xtandi to its portfolio...
